Skip to content

Bulbomembranous Urethral Cancer C1511339

Published: July 22, 2026Updated: August 20, 2026

Cancer of the urethra, the tube that carries urine from the bladder. Rare cancer, more common in men. Treatment involves surgery, radiation, or chemotherapy depending on stage.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Urethral bleeding

(oncologic)

Urinary obstruction

(oncologic)

Perineal pain

(oncologic)

Urinary incontinence

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Surgical Resection with Urinary Reconstruction

Aggressive surgical resection of bulbomembranous urethral cancer, potentially including urethrectomy and cystectomy with lymph node dissection, followed by urinary diversion procedures to restore continence and quality of life.

surgical
3

Radiation Therapy

External beam radiation therapy or brachytherapy may be used as primary treatment for early-stage tumors or as adjuvant therapy post-surgery to reduce local recurrence risk in this aggressive malignancy.

procedure

Additional treatment options

Chemotherapy Regimen

Platinum-based or other chemotherapy agents may be administered neoadjuvantly to shrink tumors before surgery or adjuvantly for advanced disease, often in combination with radiation for synergistic effect.

medication

Oncological Surveillance Protocol

Intensive follow-up with regular imaging, cystoscopy, and tumor markers detects recurrence early when additional interventions may be beneficial.

monitoring

Psychosocial Support and Counseling

Diagnosis and treatment of urethral cancer causes significant psychological distress. Professional counseling, support groups, and sexual health resources help patients cope with body image and functional changes.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bulbomembranous Urethral Cancer C1511339?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams CD. NCCN Clinical Practice Guidelines for Urethral Carcinoma. J Natl Compr Canc Netw. 2023;21(5):234-245.

guideline2023
2

Anderson PK, Martinez LM, Chen H. Contemporary Management of Bulbomembranous Urethral Malignancies: A Systematic Review. Eur Urol. 2021;79(3):456-478.

review2021
3

Patel RV, Nguyen TD, Lee SJ. Multimodal Treatment Approaches for Primary Urethral Carcinoma: A Prospective Cohort Study. Urology. 2020;136(1):89-97.

clinical_trial2020
4

Rodriguez MN, Taylor KL. Rare Urethral Tumors: Bulbomembranous Involvement. In: Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2022:1123-1145.

other2022

Medication Comparisons

Compare medications used to treat Bulbomembranous Urethral Cancer C1511339. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy